Close menu


Photo credits:

Commented by Carsten Mainitz on February 22nd, 2022 | 10:49 CET

Bayer, Memiontec, Dr. Hönle - Serious threat!

  • Investments

Water is the basis of all life. We use water for our nutrition, daily hygiene and leisure activities. Water is also a crucial economic factor as an energy source, transport medium and raw material. But access to clean drinking water is not a matter of course; even today, 1 billion people are denied it. According to various experts, this situation will soon deteriorate dramatically. By 2025, 3 billion people could be living in countries with severe water shortages. Therefore, water scarcity is an urgent issue for the future of humanity.


Commented by Carsten Mainitz on February 18th, 2022 | 12:47 CET

Commerzbank, wallstreet:online, Bayer - Positive signals!

  • Investments

The US Federal Reserve is on the verge of ending its ultra-loose monetary policy and is signaling interest rate hikes soon in order to get a grip on high inflation, which is currently far above the target value of 2%. In addition, the monetary watchdogs cite future inflation risks and the robust labor market as reasons for the rising interest rates. As a result, shares of banks and financial services providers are benefiting. The successful restructuring measures, which are now generating billions in profits for the banks, also boost share prices.


Commented by Juliane Zielonka on February 17th, 2022 | 12:10 CET

Peloton, Diamcor, Bayer - Trust, tangibles and expertise

  • Diamonds

Peloton gets in shape with streamlining just like its existing customers. 90% of early adopters remain loyal to the Company. Rough diamonds achieve new record prices, Diamcor profits, and so do its investors. Bayer comes up trumps in the agricultural business with innovative solutions for corn cultivation. In the upcoming market phase, investors want to be prepared. Investing in price-setters that take advantage of strong inflation makes sense. We take a look at three investment opportunities.


Commented by Armin Schulz on February 7th, 2022 | 12:14 CET

Bayer, Perimeter Medical Imaging AI, Siemens Healthineers - Diagnostics as an upcoming trend in the pharmaceutical industry

  • medtech

The Corona pandemic has made many people aware of the importance of diagnostics. Without PCR and antigen tests, it would have been impossible to control the incidence of infection. But it is not only in this area that things have changed in the last 2 years. Diagnostics are becoming increasingly digitized, and so more and more tech companies are entering the market that originally had nothing to do with the pharmaceutical industry. The better the diagnostics, the earlier diseases can be detected and treated. It is a future topic in pharma. We look at three companies from this sector today.


Commented by Stefan Feulner on February 2nd, 2022 | 12:45 CET

Bayer, Almonty Industries, HeidelbergCement - Delivered

  • Tungsten

To start, the good news, the inflation rate fell in January for the first time since December 2020. However, the level of 4.9% remains at a threateningly high level, and economists had expected a sharper fall. The main reasons for the inflation are the continued exorbitant rise in energy prices and rising commodities prices. High inflation is reducing consumers' purchasing power. In addition, rising production costs are squeezing companies' margins.


Commented by Nico Popp on January 26th, 2022 | 11:01 CET

Bayer, MAS Gold, BASF: 5.7% dividend? These intrinsic values score now!

  • Gold

According to capital market strategist Ulrich Stephan from Deutsche Bank, substantial stocks could have an advantage in the upcoming market phase. The reason: When interest rates rise, the refinancing costs for growth companies increase significantly, as they usually do not write any or few profits. Reason enough to take a closer look at two of the best-known German substance companies and ask whether there are also growth stocks with substance.


Commented by Nico Popp on January 13th, 2022 | 11:03 CET

Bayer, First Hydrogen, NEL: This is how innovative investing works!

  • Hydrogen

Innovation pays off - especially on the stock market. That is because innovative products generate price fantasy, which can generate rich returns on the stock market within a very short period of time. In addition to classic trend themes, such as hydrogen, established companies can also score with innovations. We present three stocks and explain whether they offer opportunities or not.


Commented by Armin Schulz on January 12th, 2022 | 13:42 CET

Bayer, XPhyto Therapeutics, MorphoSys - Which pharmaceutical companies bring returns?

  • Biotechnology

Most recently, the pharmaceutical industry has been accused of being greedy and getting rich off Corona. While it is true that 2021 has been dominated by vaccine news, the industry can do much more than just produce vaccines against Corona. Handelsblatt ran a headline on January 10, "In the shadow of Corona," citing the growing number of cancers over the past several years. This year, more than 45 new drugs are expected to hit the market to help fight cancer and genetic defects, among other things. Today, we look at three companies that do not make Corona vaccines.


Commented by Stefan Feulner on January 11th, 2022 | 11:20 CET

Steinhoff, Aspermont, Bayer - Crazy speed

  • Digitization

In terms of digitization, Germany lags light years behind other countries. Most of the big Internet success stories were written in the USA with Facebook, Google, Amazon and Apple. Yet new developments are coming faster and faster, and the digital transformation continues unabated. Down Under, the next success story is currently being built: The transformation of a venerable publishing house into a digital media company. The next big step is on the horizon, which should bring great potential for investors with the help of new shareholders. But the story is still in its infancy.


Commented by Stefan Feulner on January 5th, 2022 | 11:10 CET

Avoiding penalties with Bayer, MAS Gold and BASF

  • Gold

According to the "Allianz Global Wealth Report", global financial assets have grown strongly. Private households alone had gross financial assets of over EUR 200 trillion worldwide in the past year, representing an increase of almost 10% compared to the previous year. The reason for the high savings rate was mainly the uncertainty surrounding the Corona pandemic. Now, with punitive interest rates and rising inflation, there are renewed threats to citizens' assets. One way out would be to invest in precious metals and build up long-term equity positions, primarily in the value sector.